medigraphic.com
SPANISH

Acta Médica de Cuba

ISSN 1561-3186 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 2

<< Back Next >>

Rev Acta Médica 2021; 22 (2)

Evaluation of therapeutic adherence in elderly asthmatic patients

Ginard CA, Ceballos RE, Báez LJM, Figueroa GI, Estruch FIM
Full text How to cite this article

Language: Spanish
References: 39
Page:
PDF size: 1244.87 Kb.


Key words:

therapeutic adherence, comorbidities, exacerbations, inhalation technique, asthma.

ABSTRACT

Introduction: Bronchial asthma is a chronic inflammatory disease of the airways, various cells and mediators of inflammation intervene in its pathogenesis. Most of the elderly do not comply with the indicated treatment and non-adherence to prescribed medication is a major cause of asthma, which is difficult to treat.
Objective: To assess the therapeutic adherence in the asthmatic elderly from the Allergology Service at “Hermanos Ameijeiras” Surgical Clinical Hospital, from October 2018 to December 2019, as well as to identify the non-adherence factors to establish action plans aimed at increasing compliance with the prescriptions, adequate control of the condition and better quality of life in these patients.
Methods: A descriptive, cross-sectional study was carried out in 62 patients characterized according to demographic and clinical variables. Morinsky-Green Levine test was used to determine therapeutic adherence. Factors associated with non-adherence were analyzed; the use of the inhalation technique and the association between therapeutic adherence and inhalation technique, asthma control and exacerbations were evaluated. For statistical processing, summary measures were applied for qualitative and quantitative variables and tests of association Chi square of independence and Bartholomew's Chi square.
Results: Female sex (96.8%), non-smokers (62.9%), comorbidities such as hypertension (79%) and ischemic heart disease (45.2%) predominated; the mean duration of the disease was 40.6 years; 53.2% of the patients were partially controlled; 59.7% are not adherent to the treatment; 75.8% showed incorrect inhalation technique; and we observed a possible statistically significant association between therapeutic adherence and inhalation technique, asthma control and exacerbations.
Conclusions: Most of the asthmatic elderly studied are not well-adherent to treatment.


REFERENCES

  1. Comité ejecutivo de la GEMA. Guía española para el manejo del asma.SEMG. 2019[acceso: 29/09/2020]. Disponible en:https://semg.es/index.php/consensos guias-y-protocolos/316-gema-4-4-g

  2. McBrien CN, Menzies A. Less is more: the impact of maintenance treatmentadherence in severe asthma clinical trials. Eur Respir J. 2019;53:1-3. DOI:https://doi.org/10.1183/13993003.00599-2019

  3. Padmanabhan M, Tamilarasu K, Rajaram M, Batmanabane G. Inadequateinhaler technique, an everlasting problem associated with poor diseasecontrol-across-sectional study. Adv Respir Med. 2019;87: 217–225. DOI:https://doi.org/10.5603/ARM.2019.0036

  4. GBD 2015. Chronic Respiratory Disease Collaborators. Global, regional, andnational deaths, prevalence, disability-adjusted life years, and years livedwith disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Respir Med. 2017[acceso: 29/09/2020];5(9):691-706. Disponible en:https://pubmed.ncbi.nlm.nih.gov/28822787/

  5. Hassann M, Davies SE, Trethewey SP, Mansur AH. Prevalence and predictorsof adherence to controller therapy in adult patients with severe/difficult-totreatasthma: a systematic review and meta-analysis. J Asthma. 2019[acceso:20/08/2020]:1-11. DOI: https://doi.org/10.1080/02770903.2019.1645169

  6. Jung E, Yeong M, Hoon S, Eun Y, Kyung H, Heon S, et al. Implementation ofAsthma Management Guidelines and Possible Barriers in Korea. J Korean MedSci. 2020;35(12): e72. DOI: https://doi.org/10.3346/jkms.2020.35.e72

  7. Mora GR, Verdecía K, Rodríguez TM, del Pino BN, Guerra C. Adherenciaterapéutica en pacientes con algunas enfermedades crónicas o transmisibles.Rev Cub Med Gen. 2017[acceso:19/07/2020];33(3):[aprox 8 p.]. Disponible en:http://scielo.sld.cu/scielo.php?scrip=sciarttext&pid=S086421252017000300001&nrm=iso

  8. Climent M, Martínez E. Asma bronquial en el anciano. Rev Asma.2018[acceso: 02/10/2020] ;3(3):82-8 Disponible en:https://www.separcontenidos.es/revista3/index.php/revista/article/view/140/190

  9. Ginard A, Ceballos E, Báez JM, Figueroa I, Estruch I. Evaluación defenotipos de ama en pacientes de la tercera edad. Rev Act Med.2019[acceso:22/09/2020];20(1):[aprox4p]. Disponible en:http://www.revactamedica.sld.cu/index.php/act/issue/view/1

  10. Pereira LE, de Sá LO, Teixeira NM. Adesão ao regime terapêuticomedicamentoso e aspectos biopsicossociais dos idosos integrados em cuidados continuados domiciliários. Rev. Gaúcha Enferm. 2017;38(3): [aprox 5 p]. DOI:http://dx.doi.org/10.1590/1983-1447.2017.03.56234

  11. Hua M, Zhi Y, Fen L, Lin H, Thumboo J. Prevalence of and factorsassociated with primary medication non-adherence in chronic disease: Asystematic review and metaanalysis. Int J Clin Pract. 2019;73:e13350. DOI:https://doi.org/10.1111/ijcp.13350

  12. Megret R, Dorela T. Calles DT. Adherencia terapéutica en pacientes conenfermedades crónicas hospitalizados en un Servicio de Medicina Interna. JPharm Pharmacogn Res. 2018[acceso: 29/09/2020];6(5): 349-57. Disponibleen: https://jppres.com/jppres/adherencia-terapéutica-en-pacientes-conenfermedades-crónicas/

  13. Shahin W, Kennedy GA, Stupans I. The impact of personal and culturalbeliefs on medication adherence of patients with chronic illnesses: asystematic review. Pat Pref Adh J. 2019;13:1019–35. DOI:http://doi.org/10.2147/PPA.S212046

  14. Porto D, Sidney S, Tarouco B, Ilha S, Calcagno G. Elderly receivingoutpatient care: reasons for adherence/nonadherence to medication. Textcont enferm. 2015;24(4):[aprox 3 p]. DOI: http://dx.doi.org/10.1590/0104-0707201500002230014

  15. Rodríguez L, Saracco R, Escamilla R, Fresán A. Validez de la Escala deEvaluación Cognitiva de Montreal (MoCA) para determinar deterioro cognitivoen pacientes con esquizofrenia. Rev S Ment.2014[acceso:09/09/2020];37(6):517-22. Disponibleen:https://www.medigraphic.com/cgibin/new/resumen.cgi?IDARTICULO=57074

  16. Gómez Angulo C, Campo Arias A. Escala de Yesavage para DepresiónGeriátrica (GDS-15 y GDS-5): estudio de la consistencia interna y estructurafactorial. Univ. Psychol. 2011[acceso:22/09/2020];10(3):[aprox 4 p].Disponible en:http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-92672011000300008

  17. 17 Alvarez M, Alaiz AT, Brun E. Capacidad funcional de pacientes mayores de65 años, según el índice de Katz. Fiabilidad del método. Aten Prim.1992[acceso: 15/10/2020];10(6):812-16. Disponible en:https://dialnet.unirioja.es/servlet/articulo?codigo=7535150

  18. Concurrent and predictive validity of a self-reported measure ofmedication adherence. Med Care. 1986[acceso:15/10/2020];24(1):67-74.Disponible en: https://pubmed.ncbi.nlm.nih.gov/3945130/

  19. Vega JM, Badia X, Badiola C, López A, Olaguíbel JM, Picado C, et al.Covalair Investigator Group. Validation of the Spanish version of the AsthmaControl Test (ACT). J Asthma. 2007[acceso:29/09/2020];44(10):867-72.Disponible en: https://pubmed.ncbi.nlm.nih.gov/18097865/

  20. World Medical Association. Declaraion of Helsinki. Ethical principles formedical research involving human sublects. Adopted gy the 18th WMA GeneralAssembly, Helsinki, Finland, June 1964, and amended by the: 59thWMAGeneral Assembly, Seoul. 2013[acceso:11/09/2020]. Disponible en:http://www.wma.net

  21. Ministerio de Salud Pública de Cuba, Dirección de registros médicos yestadísticas de salud. Anuario estadístico de salud 2019. La Habana: MINSAP.2020[acceso:11/09/2020]:96-7. Disponible en:https://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  22. Enríquez A. Características clínicas de pacientes mayores de 65 añosdiagnosticados de asma: calidad de vida, control de la enfermedad yevolución de la función pulmonar. (Tesis doctoral).2016[acceso:29/09/2020]:[aprox226p]. Disponible en:https://eprints.ucm.es/id/eprint/41278/1/T38415.pdf

  23. Leija G, Peláez V, Pérez E, Pablo R, Orea A, Domínguez B, et al. Factorescognitivos predictivos de adherencia terapéutica en personas con sobrepeso yobesidad. Rev Mex trast alim. 2019;10(1):[aprox 7 p]. DOI:http://dx.doi.org/10.22201/fesi.20071523e.2019.1.451

  24. Porto D, Sidney S, Tarouco B, Calcagno G, Dias V, Gonçalves C.Prevalencia de la adhesión al tratamiento farmacológico en ancianos yfactores relacionados. Rev Bras Enferm. 2016;69(2):[aprox4p]. DOI:http://dx.doi.org/10.1590/0034-7167.2016690217i

  25. Rivera L. Prescripción inadecuada de fármacos y su relación con elcumplimiento terapéutico en pacientes polimedicados. J Gerok.2018[acceso:21/09/2020];29(3):[aprox 2 p]. Disponible en:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134928X2018000300123&lng=es&nrm=iso

  26. Booster GD, Oland AA, Bender BG.Treatment Adherence in Young Childrenwith Asthma. Immunol Allergy Clin North Am. 2019;39(2):233-42. DOI:https://doi.org/10.1016/j.iac.2018.12.006

  27. Hedenrud T, Jakobsson A, El Malla H, Hakonsen H. “I did not know it wasso important to take it the whole time” − self-reported barriers to medicaltreatment among individuals with asthma. BMC Pulm Med.2019[acceso:04/07/2020];19:175. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751752/

  28. Desager K, Vermeulen F, Bodart E. Adherence to asthma treatment inchildhood and adolescence - a narrative literature review. Acta Clin Belg.2018;73(5):348-55. DOI: https://doi.org/10.1080/17843286.2017.1409684

  29. Valero S, Pérez M, Montoya I, Castillo S, Ramírez A, Escribano A. Malestaremocional en los familiares de adolescentes con asma bronquial: análisis desus predictores. Arch argent ped. 2018;116(2):[aprox 3 p]. DOI:http://dx.doi.org/10.5546/aap.2018.e234

  30. Parra DI, Romero SL, Rojas LZ. Influential Factors in Adherence to theTherapeutic Regime in Hypertension and Diabetes. Invest Educ Enferm.2019[acceso:17/06/2020];37(3):e02. Disponible en:http://www.scielo.org.co/pdf/iee/v37n3/2216-0280-iee-37-03-e02.pdf

  31. Honorato J. Adherencia al tratamiento farmacológico. Rev Med Resp.2015[acceso:17/06/2020];8(1):47-52. Disponible en:http://www.neumologiaysalud.es/descargas/R8/R81-6.pdf

  32. Pike KC, Levy ML, Moreiras J, Fleming L. Managing problematic severeasthma: beyond the guidelines. Arch Dis Child.2018[acceso:29/09/2020];103(4):392-7. Disponible en:http://adc.bmj.com/content/early/2017/09/12/archdischild-2016-311368

  33. Manríquez P, Acuña AM, Muñoz L, Reyes A. Estudio sobre la técnicainhalatoria en pacientes asmáticos: diferencias entre pacientes pediátricos yadultos mayores. J Bras Pneumol. 2015[acceso:22/08/2020];41(5):405–9.Disponible en: https://www.scielo.br/pdf/jbpneu/v41n5/es_1806-3713-jbpneu-41-05-00405.pdf

  34. Ramos LE. La adherencia al tratamiento en las enfermedades crónicas.Rev Cub Angiol Cir Vasc. 2015[acceso:22/08/2020];16(2):[aprox 6 p.]Disponible en: http://scielo.sld.cu/scielo.php?script=sciarttext&pid=S1682-0037015000200006

  35. Brinkman P, Ahmed WM, Gómez C, Knobel HH, Weda H, Vink TJ, et al.Exhaled volatile organic compounds as markers for medication use in asthma.Eur Respir J.2020;27;55(2). DOI: https://doi.org/10.1183/13993003.00544-2019

  36. Takemura M, Kobayashi M, Kimura K, Mitsui K, Masui H, Fukui M, et al.Repeated inhalation technique improves adherence to the therapeuticrégimen in asthma. The Journal Of Asthma: Official Journal Of The AssociationFor The Care Of Asthma. 2014[acceso:14/08/2020];47(2):[aprox. 20 p].Disponible en:http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=29170330&lang=es&site=ehost-live

  37. Mora GR, Verdecia K, Rodríguez TM, del Pino BN, Guerra C. Adherenciaterapéutica en pacientes con algunas enfermedades crónicas no transmisibles.Rev Cub Med Gen Integr. 2017[acceso: 29/09/2020];33(3):[aprox 3 p].Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/309

  38. Nastałek P, Kurek A, Almgren A, Mastalerz A, Doniec Z. Factors affectingthe choice of therapeutic regimens in asthma and chronic obstructivepulmonary disease patients and patient adherence to the therapiesprescribed. Adv Dermatol Allergol. 2019;XXXVI(2):202–10. DOI:https://doi.org/10.5114/ada.2018.76144

  39. Bosley Barnes C, Suppli Ulrik C. Asthma and Adherence to InhaledCorticosteroids: Current Status and Future Perspectives. Respir Care.2015[acceso:05/10/2020];60(3):455-68. Disponible en:https://pubmed.ncbi.nlm.nih.gov/25118311/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Acta Médica. 2021;22